CD4 and neoplasm: Analyses of these five TNFR2+ lymphocyte subsets in the tumors and spleens of vehicle-treated tumor-bearing mice revealed a significantly higher percentage of all of them—of the CD4+ arm, as well as the CD8+ arm—in TILs compared to splenocytes (Figure 2B1,B2).